A new, powerful Citizen Portal experience is ready. Switch now

Committee members probe PFAS policy options: procurement, labeling, biosolids and the cost of remediation

March 03, 2026 | 2026 Legislature MN, Minnesota


This article was created by AI summarizing key points discussed. AI makes mistakes, so for full details and context, please refer to the video of the full meeting. Please report any errors so we can fix them. Report an error »

Committee members probe PFAS policy options: procurement, labeling, biosolids and the cost of remediation
Committee members used the testimony to explore practical policy levers and implications for Minnesota, focusing on procurement rules, labeling, biosolids management, insurance liabilities and infrastructure costs.

Members asked whether states can use public procurement to drive the market away from products containing intentionally added PFAS. The testifier said Michigan adopted a procurement policy in recent years but implementation has been uneven; she advised clear PFAS definitions and better labeling to enable effective state purchasing rules. “States have the power to drive this market,” she told the committee, but added that implementation and industry response vary.

Discussion also addressed biosolids: members asked how wastewater treatment solids (biosolids) can spread PFAS to farmland and whether wastewater operators and distributors keep records that would allow regulators to trace biosolids distribution. The testifier said some states now require recording biosolids distribution and pre‑treatment requirements for industries discharging to wastewater systems, but allowable PFAS levels in biosolids differ by state.

Members noted that settlements such as those involving 3M have not covered the majority of projected state cleanup costs. A member cited an estimate of up to $20 billion to address wastewater infrastructure statewide. Committee members flagged insurance companies’ reluctance to cover PFAS‑related liabilities as a market signal that could influence manufacturers.

Procedural items: the committee approved the Feb. 26 minutes by unanimous consent and scheduled follow‑up work; members identified House file 33,22 (referenced during discussion) as pending bipartisan legislation that may warrant coordination across committees.

No formal policy votes on PFAS regulation or funding were taken at this meeting; members signaled interest in staff work and future committee discussion to consider procurement pilots, labeling standards and state funding for community testing.

View the Full Meeting & All Its Details

This article offers just a summary. Unlock complete video, transcripts, and insights as a Founder Member.

Watch full, unedited meeting videos
Search every word spoken in unlimited transcripts
AI summaries & real-time alerts (all government levels)
Permanent access to expanding government content
Access Full Meeting

30-day money-back guarantee